Carregant...
Cyclosporine 0.1% (Ikervis(®)) as a corticoid-sparing agent in Lyell syndrome with KeraKlear(®) keratoprosthesis
Cyclosporine 0.1% was used in a patient with Lyell syndrome, which had undergone a KeraKlear(®) keratoprosthesis implant due to the severe ocular involvement to avoid overuse of corticoid agents. To the best of our knowledge, this is the first reported case of cyclosporine 0.1% eye drops to use in L...
Guardat en:
| Publicat a: | Taiwan J Ophthalmol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wolters Kluwer - Medknow
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7787086/ https://ncbi.nlm.nih.gov/pubmed/33437608 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/tjo.tjo_1_20 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|